comparemela.com

Latest Breaking News On - Houston liver institute - Page 1 : comparemela.com

Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results

Study Conducted with Arizona Liver Health Met Primary Endpoint and Established Proof-of-Concept for Prescription Digital Therapy Platform to Improve Disease Biomarkers in NAFLD and NASH. | December 8, 2022

United-states
Arizona
Houston
Texas
Americans
Mark-berman
Mazen-noureddin
Naim-alkhouri
Houston-liver-institute
Fatty-liver-program-at-arizona-health
Nasdaq
Better-therapeutics-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.